| |
|
|
|
Proteostasis Therapeutics Inc.  
|
|
1.27 0.01 (0.01%) |
09-18 16:00 |
|
Open: |
1.27 |
Pre close: |
1.26 |
Target:
|
1.61
|
|
High: |
1.31 |
Low: |
1.24 |
Resistance:
|
1.38
1.60
|
|
Volume: |
445,432 |
Market Cap: |
66M |
Support:
|
1.03
0.86
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.27
 |
MACD |
MACD(12,26):
|
-0.03  |
|
MA(20): |
1.32 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
1.44 |
Stochastic Oscillator |
%K(14,3):
|
41.50 |
|
MA(250): |
1.51 |
%D(3): |
48.99 |
|
Average Volume(K) |
3-Month: |
97507
|
52-Week |
High:
|
4.72 |
|
10-Days: |
43749 |
Low: |
0.70 |
|
RSI |
RSI(14):
|
41.84 |
Change(%): |
29.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.841 |
Return on Equity (ttm) |
-68.5 |
Shares Out. (M) |
52.18 |
|
EPS Est. Current Year |
-2.750 |
Return on Assets (ttm) |
-32.8 |
Shares Float (M) |
44.17 |
|
EPS Est. Next Year |
-2.450 |
PEG Ratio |
0.00 |
% Held by Insiders |
17.86 |
|
EPS Est. Next Quarter |
-0.750 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
22.55 |
|
Forward EPS |
-1.160 |
Gross Profit (p.s.) |
0.096 |
Shares Short (K) |
2300 |
|
Book Value (p.s.) |
0.860 |
EBITDA (p.s.) |
-0.826 |
P/E |
-1.51 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.48 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-43.56 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-26.77 |
P/CF |
-1.52 |
|
|
|
|
|
|
